Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data Sells IVD Business for $20M as Part of Plan to Focus on PGx Rx and Dx Plays

NEW YORK (GenomeWeb News) — Clinical Data today said it has sold its Netherlands-based in vitro diagnostics business Vital Scientific to French company ELITech Group for $19.5 million in cash.
The actual sale price was $15 million, but Clinical Data said it retained $4.5 million in cash from Vital Scientific immediately before the sale.
CEO Drew Fromkin said the divestiture is “the latest and most significant step” in Clinical Data’s plan to “devote all of our resources to our IP-driven pharmacogenomics tests and targeted therapeutics, as well as our genomics services division.”
ELITech President Pierre Debiais said the acquisition is important to his firm because “it complements the company's current portfolio of IVD products and, in particular, its clinical reagents business.”
Clinical Data said this is the third move it has made to let go of its IVD enterprises. The company last November sold its Australia-based Vital Diagnostics business for $1 million, and in June this year it sold its US-based Clinical Data Sales and Service arm for around $7 million.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.